Targeted therapy momelotinib provides significant symptom and anemia improvements in patients with myelofibrosis
Newswise — Patients with myelofibrosis had clinically significant improvement in disease-related symptoms, including anemia and spleen enlargement, when treated with the targeted therapy momelotinib, according to results from…
Read more Targeted therapy momelotinib provides significant symptom and anemia improvements in patients with myelofibrosis